| 28274957 |
An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer
Hyman, DM,
Solit, DB,
Nagy, R,
Sheehan, JH,
Sliwoski, GR,
Berger, MF,
He, J,
Lalani, AS,
Brewer, MR,
Miller, V,
Cross, D,
Cutler, RE,
Hanker, AB,
Lanman, R,
Arteaga, CL,
Koch, JP,
Lovly, CM,
Meiler, J
|
Cancer Discov |
2017 |
| 23948973 |
Human breast cancer cells harboring a gatekeeper T798M mutation in HER2 overexpress EGFR ligands and are sensitive to dual inhibition of EGFR and HER2
Song, Y,
Estrada, MV,
Arteaga, CL,
Chakrabarty, A,
Narasanna, A,
Ghosh, R,
Rexer, BN,
Engelman, JA
|
Clin. Cancer Res. |
2013 |
